- Home
- CELU vs CMBM Comparison
CELU vs CMBM Comparison
Compare CELU & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- CMBM
- Stock Information
- Founded
- CELU 2016
- CMBM 2011
- Country
- CELU United States
- CMBM United States
- Employees
- CELU N/A
- CMBM N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- CELU Health Care
- CMBM Technology
- Exchange
- CELU Nasdaq
- CMBM Nasdaq
- Market Cap
- CELU 56.9M
- CMBM 65.5M
- IPO Year
- CELU N/A
- CMBM 2019
- Fundamental
- Price
- CELU $1.96
- CMBM $1.99
- Analyst Decision
- CELU Strong Buy
- CMBM
- Analyst Count
- CELU 1
- CMBM 0
- Target Price
- CELU $6.00
- CMBM N/A
- AVG Volume (30 Days)
- CELU 69.1K
- CMBM 21.9M
- Earning Date
- CELU 11-14-2025
- CMBM 11-06-2025
- Dividend Yield
- CELU N/A
- CMBM N/A
- EPS Growth
- CELU N/A
- CMBM N/A
- EPS
- CELU N/A
- CMBM N/A
- Revenue
- CELU $40,578,000.00
- CMBM $172,215,000.00
- Revenue This Year
- CELU N/A
- CMBM N/A
- Revenue Next Year
- CELU $76.00
- CMBM $18.01
- P/E Ratio
- CELU N/A
- CMBM N/A
- Revenue Growth
- CELU N/A
- CMBM N/A
- 52 Week Low
- CELU $1.00
- CMBM $0.23
- 52 Week High
- CELU $4.35
- CMBM $6.80
- Technical
- Relative Strength Index (RSI)
- CELU 57.50
- CMBM 47.66
- Support Level
- CELU $1.62
- CMBM $1.95
- Resistance Level
- CELU $2.29
- CMBM $2.97
- Average True Range (ATR)
- CELU 0.15
- CMBM 0.49
- MACD
- CELU 0.06
- CMBM -0.14
- Stochastic Oscillator
- CELU 63.29
- CMBM 1.97
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.